Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Costello Syndrome | 8 | 2022 | 17 | 2.110 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 3 | 2019 | 45 | 1.440 |
Why?
|
| Behavior Therapy | 4 | 2022 | 269 | 1.290 |
Why?
|
| Child Behavior Disorders | 3 | 2016 | 70 | 1.160 |
Why?
|
| Disorders of Sex Development | 6 | 2019 | 71 | 1.090 |
Why?
|
| Gender Identity | 4 | 2023 | 74 | 0.990 |
Why?
|
| Psychotherapy, Brief | 2 | 2019 | 57 | 0.900 |
Why?
|
| Transgender Persons | 2 | 2023 | 68 | 0.880 |
Why?
|
| Child Behavior | 2 | 2019 | 236 | 0.800 |
Why?
|
| Problem Behavior | 1 | 2022 | 41 | 0.740 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 236 | 0.620 |
Why?
|
| Hypothalamic Diseases | 1 | 2019 | 38 | 0.610 |
Why?
|
| Hamartoma | 1 | 2019 | 52 | 0.610 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 4 | 2019 | 174 | 0.610 |
Why?
|
| Adaptation, Psychological | 4 | 2013 | 455 | 0.550 |
Why?
|
| Parenting | 2 | 2013 | 349 | 0.540 |
Why?
|
| Diabetes Mellitus, Type 1 | 7 | 2014 | 861 | 0.510 |
Why?
|
| Models, Statistical | 1 | 2017 | 495 | 0.440 |
Why?
|
| Abnormalities, Multiple | 5 | 2019 | 982 | 0.410 |
Why?
|
| Mothers | 1 | 2016 | 372 | 0.410 |
Why?
|
| Verbal Learning | 1 | 2013 | 71 | 0.400 |
Why?
|
| Child | 25 | 2022 | 25783 | 0.390 |
Why?
|
| Depressive Disorder | 1 | 2016 | 481 | 0.390 |
Why?
|
| Stress, Psychological | 2 | 2014 | 577 | 0.380 |
Why?
|
| Cognition | 3 | 2009 | 811 | 0.380 |
Why?
|
| Child Development | 1 | 2014 | 271 | 0.370 |
Why?
|
| Parent-Child Relations | 1 | 2013 | 253 | 0.360 |
Why?
|
| Autism Spectrum Disorder | 1 | 2017 | 430 | 0.360 |
Why?
|
| Neuroimaging | 1 | 2014 | 375 | 0.350 |
Why?
|
| Behavioral Symptoms | 1 | 2011 | 25 | 0.350 |
Why?
|
| Cognition Disorders | 2 | 2014 | 571 | 0.340 |
Why?
|
| Child, Preschool | 16 | 2020 | 14736 | 0.330 |
Why?
|
| Memory | 1 | 2013 | 356 | 0.320 |
Why?
|
| Behavior | 1 | 2009 | 74 | 0.310 |
Why?
|
| Parents | 4 | 2022 | 1080 | 0.310 |
Why?
|
| Outpatient Clinics, Hospital | 2 | 2013 | 77 | 0.310 |
Why?
|
| Adolescent | 20 | 2023 | 20556 | 0.300 |
Why?
|
| Syndrome | 4 | 2008 | 1175 | 0.300 |
Why?
|
| Consensus | 1 | 2012 | 658 | 0.290 |
Why?
|
| Female | 30 | 2023 | 70780 | 0.280 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 272 | 0.280 |
Why?
|
| Male | 30 | 2023 | 65013 | 0.280 |
Why?
|
| Humans | 43 | 2023 | 132238 | 0.270 |
Why?
|
| Polyhydramnios | 1 | 2007 | 56 | 0.270 |
Why?
|
| Neurocognitive Disorders | 2 | 2020 | 78 | 0.270 |
Why?
|
| Depression | 1 | 2016 | 1350 | 0.270 |
Why?
|
| Child Health Services | 1 | 2008 | 85 | 0.270 |
Why?
|
| Failure to Thrive | 1 | 2007 | 91 | 0.270 |
Why?
|
| Adrenal Hyperplasia, Congenital | 2 | 2018 | 34 | 0.250 |
Why?
|
| Urogenital Abnormalities | 2 | 2020 | 167 | 0.240 |
Why?
|
| Patient Care Team | 2 | 2016 | 576 | 0.240 |
Why?
|
| Patient Compliance | 4 | 2013 | 473 | 0.230 |
Why?
|
| Developmental Disabilities | 4 | 2020 | 749 | 0.230 |
Why?
|
| Anxiety Disorders | 1 | 2011 | 734 | 0.220 |
Why?
|
| Dwarfism | 2 | 2020 | 104 | 0.210 |
Why?
|
| Decision Making | 1 | 2009 | 699 | 0.200 |
Why?
|
| Intellectual Disability | 2 | 2007 | 1094 | 0.200 |
Why?
|
| Terminology as Topic | 2 | 2017 | 232 | 0.190 |
Why?
|
| Social Stigma | 1 | 2023 | 85 | 0.190 |
Why?
|
| Noonan Syndrome | 1 | 2022 | 32 | 0.180 |
Why?
|
| Hyperglycemia | 2 | 2014 | 235 | 0.180 |
Why?
|
| Wnt-5a Protein | 1 | 2020 | 24 | 0.170 |
Why?
|
| Dishevelled Proteins | 1 | 2020 | 44 | 0.170 |
Why?
|
| Phenotype | 6 | 2020 | 4540 | 0.160 |
Why?
|
| Craniofacial Abnormalities | 2 | 2020 | 253 | 0.160 |
Why?
|
| Limb Deformities, Congenital | 1 | 2020 | 112 | 0.160 |
Why?
|
| Heart Defects, Congenital | 4 | 2019 | 1866 | 0.160 |
Why?
|
| Mental Health | 1 | 2023 | 377 | 0.150 |
Why?
|
| Interdisciplinary Communication | 2 | 2017 | 133 | 0.150 |
Why?
|
| Puberty | 2 | 2016 | 104 | 0.150 |
Why?
|
| Adult | 13 | 2020 | 31614 | 0.150 |
Why?
|
| Medicaid | 1 | 2021 | 248 | 0.140 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2021 | 482 | 0.140 |
Why?
|
| Sex Determination Processes | 1 | 2017 | 11 | 0.140 |
Why?
|
| Genes, ras | 2 | 2008 | 100 | 0.140 |
Why?
|
| Young Adult | 6 | 2020 | 9966 | 0.140 |
Why?
|
| Sex Counseling | 1 | 2017 | 6 | 0.130 |
Why?
|
| Mythology | 1 | 2017 | 8 | 0.130 |
Why?
|
| Comorbidity | 1 | 2022 | 1610 | 0.130 |
Why?
|
| Dexamethasone | 1 | 2018 | 273 | 0.130 |
Why?
|
| Longitudinal Studies | 3 | 2013 | 1500 | 0.130 |
Why?
|
| Intelligence Tests | 2 | 2007 | 63 | 0.120 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2016 | 17 | 0.120 |
Why?
|
| Turner Syndrome | 1 | 2016 | 45 | 0.120 |
Why?
|
| Anxiety | 1 | 2023 | 1001 | 0.120 |
Why?
|
| Mutation | 4 | 2011 | 6250 | 0.120 |
Why?
|
| Mother-Child Relations | 1 | 2016 | 80 | 0.120 |
Why?
|
| Ectromelia | 1 | 2015 | 4 | 0.120 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 2015 | 26 | 0.120 |
Why?
|
| Cohort Studies | 4 | 2013 | 5176 | 0.120 |
Why?
|
| Social Behavior | 1 | 2017 | 225 | 0.120 |
Why?
|
| Sexual Development | 2 | 2019 | 24 | 0.110 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 115 | 0.110 |
Why?
|
| Encephalocele | 1 | 2015 | 48 | 0.110 |
Why?
|
| Heart | 1 | 2019 | 689 | 0.110 |
Why?
|
| Fertility | 1 | 2016 | 260 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 3 | 2017 | 1307 | 0.110 |
Why?
|
| Infant | 6 | 2017 | 13049 | 0.110 |
Why?
|
| Germ-Line Mutation | 3 | 2019 | 368 | 0.110 |
Why?
|
| Neuropsychological Tests | 2 | 2015 | 990 | 0.100 |
Why?
|
| Language Tests | 1 | 2013 | 26 | 0.100 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 88 | 0.100 |
Why?
|
| Thrombocytopenia | 1 | 2015 | 233 | 0.100 |
Why?
|
| Family | 1 | 2016 | 595 | 0.100 |
Why?
|
| Hypoglycemia | 1 | 2014 | 183 | 0.100 |
Why?
|
| Age of Onset | 1 | 2014 | 626 | 0.100 |
Why?
|
| Models, Psychological | 1 | 2013 | 144 | 0.100 |
Why?
|
| Endocrinology | 1 | 2014 | 128 | 0.090 |
Why?
|
| Stress Disorders, Traumatic, Acute | 1 | 2011 | 2 | 0.090 |
Why?
|
| Educational Measurement | 1 | 2014 | 329 | 0.090 |
Why?
|
| Infant, Newborn | 4 | 2017 | 8548 | 0.090 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2013 | 166 | 0.090 |
Why?
|
| Program Evaluation | 1 | 2013 | 456 | 0.090 |
Why?
|
| Brain | 3 | 2019 | 3194 | 0.090 |
Why?
|
| Age Factors | 1 | 2017 | 2923 | 0.080 |
Why?
|
| Manuals as Topic | 1 | 2009 | 10 | 0.080 |
Why?
|
| United States | 4 | 2021 | 11669 | 0.080 |
Why?
|
| Risk Factors | 5 | 2015 | 10944 | 0.080 |
Why?
|
| Surveys and Questionnaires | 2 | 2017 | 3995 | 0.070 |
Why?
|
| Vision, Ocular | 1 | 2009 | 132 | 0.070 |
Why?
|
| Facial Asymmetry | 1 | 2008 | 18 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2009 | 328 | 0.070 |
Why?
|
| Texas | 3 | 2013 | 3632 | 0.070 |
Why?
|
| Sex Factors | 1 | 2011 | 1354 | 0.070 |
Why?
|
| Pregnancy | 4 | 2018 | 7557 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 5410 | 0.060 |
Why?
|
| Motor Activity | 1 | 2009 | 523 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 482 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 309 | 0.060 |
Why?
|
| Heterozygote | 1 | 2007 | 715 | 0.060 |
Why?
|
| Pediatrics | 1 | 2014 | 1210 | 0.060 |
Why?
|
| Insulin | 1 | 2010 | 1168 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2013 | 13027 | 0.060 |
Why?
|
| Mental Health Services | 1 | 2008 | 281 | 0.060 |
Why?
|
| Mass Screening | 1 | 2011 | 830 | 0.060 |
Why?
|
| Vocabulary | 1 | 2004 | 23 | 0.060 |
Why?
|
| Patient Satisfaction | 1 | 2008 | 482 | 0.060 |
Why?
|
| Face | 2 | 2019 | 189 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2008 | 570 | 0.050 |
Why?
|
| Psychomotor Performance | 2 | 2015 | 182 | 0.050 |
Why?
|
| Prenatal Diagnosis | 2 | 2018 | 631 | 0.050 |
Why?
|
| Aging | 1 | 2009 | 1254 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2008 | 674 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2021 | 17395 | 0.050 |
Why?
|
| ras Proteins | 1 | 2022 | 146 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2022 | 200 | 0.040 |
Why?
|
| Managed Care Programs | 1 | 2021 | 56 | 0.040 |
Why?
|
| Quality of Life | 1 | 2010 | 2161 | 0.040 |
Why?
|
| Virilism | 1 | 2018 | 14 | 0.040 |
Why?
|
| Genotype | 2 | 2019 | 2703 | 0.040 |
Why?
|
| Hormones | 1 | 2019 | 170 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 196 | 0.040 |
Why?
|
| Sex Preselection | 1 | 2017 | 6 | 0.030 |
Why?
|
| Birth Certificates | 1 | 2017 | 13 | 0.030 |
Why?
|
| Intersectoral Collaboration | 1 | 2017 | 20 | 0.030 |
Why?
|
| Gender Dysphoria | 1 | 2017 | 7 | 0.030 |
Why?
|
| Greece, Ancient | 1 | 2017 | 9 | 0.030 |
Why?
|
| History, Ancient | 1 | 2017 | 56 | 0.030 |
Why?
|
| Ovulation Induction | 1 | 2016 | 42 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2017 | 271 | 0.030 |
Why?
|
| Fertility Preservation | 1 | 2016 | 58 | 0.030 |
Why?
|
| Alleles | 1 | 2020 | 1685 | 0.030 |
Why?
|
| Leukopenia | 1 | 1975 | 47 | 0.030 |
Why?
|
| Gonads | 1 | 2015 | 34 | 0.030 |
Why?
|
| Genitalia | 1 | 2015 | 38 | 0.030 |
Why?
|
| Disease Management | 1 | 2019 | 565 | 0.030 |
Why?
|
| Visual Perception | 1 | 2015 | 136 | 0.030 |
Why?
|
| Disclosure | 1 | 2015 | 153 | 0.030 |
Why?
|
| Androgens | 1 | 2015 | 277 | 0.020 |
Why?
|
| Estrogens | 1 | 2015 | 436 | 0.020 |
Why?
|
| Neoplasms | 3 | 2015 | 2960 | 0.020 |
Why?
|
| Informed Consent | 1 | 2015 | 346 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 1975 | 380 | 0.020 |
Why?
|
| Southwestern United States | 1 | 2011 | 45 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 600 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 3852 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 767 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 663 | 0.020 |
Why?
|
| Psychology | 1 | 2011 | 58 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 2442 | 0.020 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2011 | 72 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2014 | 1121 | 0.020 |
Why?
|
| Family Relations | 1 | 2010 | 71 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2022 | 4718 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3358 | 0.020 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2010 | 124 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2013 | 780 | 0.020 |
Why?
|
| Farnesyltranstransferase | 1 | 2008 | 8 | 0.020 |
Why?
|
| Chondroitin Sulfates | 1 | 2008 | 14 | 0.020 |
Why?
|
| Pyloric Stenosis | 1 | 2008 | 10 | 0.020 |
Why?
|
| Mental Disorders | 1 | 1975 | 893 | 0.020 |
Why?
|
| Human Growth Hormone | 1 | 2008 | 75 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 821 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2008 | 94 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2011 | 1444 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2166 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 902 | 0.020 |
Why?
|
| Time Factors | 2 | 2015 | 6451 | 0.020 |
Why?
|
| Prediabetic State | 1 | 1976 | 64 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 1976 | 163 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 826 | 0.020 |
Why?
|
| Carbonic Anhydrases | 1 | 1975 | 26 | 0.020 |
Why?
|
| Digitoxin | 1 | 1975 | 11 | 0.020 |
Why?
|
| Cadmium | 1 | 1975 | 31 | 0.020 |
Why?
|
| Mercury | 1 | 1975 | 32 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 2139 | 0.010 |
Why?
|
| Hospitalization | 1 | 2014 | 1902 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 1170 | 0.010 |
Why?
|
| Hydrolases | 1 | 1975 | 61 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 1975 | 100 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 589 | 0.010 |
Why?
|
| Zinc | 1 | 1975 | 125 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 2314 | 0.010 |
Why?
|
| Prevalence | 1 | 2011 | 2664 | 0.010 |
Why?
|
| Biomarkers | 1 | 2014 | 3404 | 0.010 |
Why?
|
| Caregivers | 1 | 2010 | 596 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2013 | 3736 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 3018 | 0.010 |
Why?
|
| Base Sequence | 1 | 2008 | 2899 | 0.010 |
Why?
|
| Lysosomes | 1 | 1975 | 261 | 0.010 |
Why?
|
| Autoantibodies | 1 | 1976 | 458 | 0.010 |
Why?
|
| Skin | 1 | 1975 | 527 | 0.010 |
Why?
|
| Middle Aged | 2 | 2020 | 29021 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1976 | 926 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1975 | 448 | 0.010 |
Why?
|
| Phenothiazines | 1 | 1975 | 6 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1975 | 16 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 1975 | 412 | 0.010 |
Why?
|
| Kinetics | 2 | 1975 | 1130 | 0.000 |
Why?
|
| Genetic Variation | 1 | 1975 | 1580 | 0.000 |
Why?
|
| Glucose Tolerance Test | 1 | 1976 | 206 | 0.000 |
Why?
|
| Chondro-4-Sulfatase | 1 | 1975 | 1 | 0.000 |
Why?
|
| Acid Phosphatase | 1 | 1975 | 14 | 0.000 |
Why?
|
| Cerebroside-Sulfatase | 1 | 1975 | 9 | 0.000 |
Why?
|
| Digitoxigenin | 1 | 1975 | 10 | 0.000 |
Why?
|
| Organ Specificity | 1 | 1976 | 412 | 0.000 |
Why?
|
| Chromatography, Thin Layer | 1 | 1975 | 45 | 0.000 |
Why?
|
| Pyrophosphatases | 1 | 1975 | 22 | 0.000 |
Why?
|
| Hydroxylation | 1 | 1975 | 51 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1975 | 161 | 0.000 |
Why?
|
| NADP | 1 | 1975 | 54 | 0.000 |
Why?
|
| HLA Antigens | 1 | 1976 | 219 | 0.000 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 1975 | 33 | 0.000 |
Why?
|
| Cattle | 1 | 1975 | 569 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1975 | 297 | 0.000 |
Why?
|
| Autoimmune Diseases | 1 | 1976 | 273 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1975 | 861 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1975 | 826 | 0.000 |
Why?
|
| Binding Sites | 1 | 1975 | 1256 | 0.000 |
Why?
|
| Protein Binding | 1 | 1975 | 1734 | 0.000 |
Why?
|
| Animals | 3 | 1975 | 34845 | 0.000 |
Why?
|
| Rats | 1 | 1975 | 3604 | 0.000 |
Why?
|
| Drug Stability | 1 | 1975 | 59 | 0.000 |
Why?
|
| Temperature | 1 | 1975 | 302 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1975 | 201 | 0.000 |
Why?
|
| Aged | 1 | 1976 | 21482 | 0.000 |
Why?
|